CareersInvestor RelationsPress RoomCOVID-19
LoginRegister

News from Siemens Healthineers

Read in the latest LinkedIn article from CEO Bernd Montag

Covid-19 is currently the most disruptive force shaking the very foundations of our tightly interwoven societies. The virus is attacking our health, our way of life, our prosperity. But it can also be seen as a wake-up call. Read in the latest LinkedIn article from CEO Bernd Montag about the chance for a "Great Reset" in healthcare.
 

Outline of Finland with the Northern lights in the background.

How does Finland's healthcare system contribute to the nation's happiness?

Learn how Finland transformed their care delivery and achieved healthcare happiness

Transforming care delivery
diagnostic accuracy
How can we overcome the challenges of today’s diagnostics?

The pandemic has exposed the current challenges of diagnostics. Learn how to overcome them and improve diagnostic accuracy.

Expanding precision medicine

How to protect healthcare workers during and beyond the COVID-19 pandemic?

 12/22/2020

Learn concrete steps to mitigate the physical risk to healthcare workers and to safeguard their well-being.

digital compass to symbolize the direction healthcare executive see for digitalizing healthcare

Who are the leaders in digital health and what can we learn from them in times of COVID-19?

 12/16/2020

The current status of digitalization around the globe. We asked healthcare executives to rate their maturity in digitalization.

Digitalizing healthcare

Contact Us

Siemens Medical Solutions USA, Inc.

40 Liberty Boulevard
Malvern, PA 19355
United States of America

Please call us anytime 24/7

Phone: 888-826-9702

1The Dosimetry Research Tool shown in the image is an Investigational Device. Limited by Federal (or United States) law to investigational use. This device is exclusively for clinical investigations. This Investigational Device does not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations. It is not commercially available in the European Union, or other countries worldwide.